The ERAP2 gene has been shown to be expressed considerably more in the CD4 + T cells of patients with RA who react to glucocorticoid medication, suggesting that ERAP2 may be a clinical predictor of response to glucocorticoid therapy in patients with RA (56). The gene discussed is CD4; the disease is rheumatoid arthritis.